Investor Relations

At the intersection of regenerative medicine and hospitality, BioLife Science is building a scalable platform for personalized health and longevity.

Contact Investor Relations

Investor Thesis

The global regenerative medicine category is expanding rapidly, supported by advances in stem cells, peptides, AI-driven personalization, and consumer demand for proactive longevity care. BioLife Science is positioned to disrupt legacy wellness models with a high-touch, data-driven, membership experience that scales.

  • Market Tailwinds: Rising adoption of precision health, hormone optimization, and recovery therapies.
  • Disruption: Science-first protocols delivered in elevated, spa-inspired centers.
  • Scalability: Standardized clinical playbooks, membership systems, and franchise-ready operations.
  • Resilience: Diversified recurring revenue and membership economics.

Governance & Board

BioLife Science operates with transparent, disciplined governance — aligning clinical integrity with sustainable growth.

  • Board of Directors: Leaders across regenerative medicine, healthcare, and franchising.
  • Medical Advisory Council: Clinicians overseeing protocol safety and compliance.
  • Corporate Governance: Ethical standards, risk management, and accountability.

Expansion Roadmap

2025

Franchise Rollout Begins

BioLife Science transitions from development to franchise activation, launching its first territories through the Founding Franchisee Program. This milestone demonstrates franchise demand, market validation, and early system adoption.

2026

Corporate Growth & Validation

Fifteen corporate-owned flagship centers across Texas become the operational blueprint, refining systems, staffing, and guest experience metrics for scalable replication.

2027+

Hybrid Growth Model

Expansion accelerates through corporate flagships, physician-franchise partners, and select international joint ventures — positioning BioLife as a global wellness brand.

BioLife’s strategy balances medical integrity with scalable growth.

Investor FAQ

What is BioLife Science?

BioLife Science is a next-generation regenerative wellness brand merging advanced biologic therapies with luxury guest experiences.

How is BioLife structured for growth?

BioLife operates a hybrid model of corporate-owned and physician-owned centers for scalability and shared standards.

What differentiates BioLife from other brands?

Each center is designed as a first-class wellness destination, combining medical precision and recurring membership revenue.

Who leads BioLife Science?

Founded by Bill Jones with a leadership team of medical, hospitality, and franchise experts.

Can I access detailed investor information?

Accredited investors may request access to detailed data via the Investor Inquiry form.

Partner in the Future of Regenerative Wellness

BioLife Science represents a rare opportunity to participate in precision-based, physician-driven wellness. Our platform is built for scalability, brand value, and long-term alignment.

Contact Investor Relations

Forward-Looking Statements

This page includes forward-looking statements regarding BioLife Science’s growth, market opportunities, and business strategy. These statements are based on current expectations and are subject to risks and uncertainties that may cause actual results to differ materially. Nothing on this page constitutes an offer to sell or a solicitation to buy securities.

Franchise Territories

Available now: Texas, Louisiana, Mississippi, Oklahoma, Florida, Alabama, Georgia. All other states: franchise territories coming soon.

United States Coverage

WA
MT
ND
MN
WI
MI
VT
NH
ME
OR
ID
SD
IA
IL
IN
OH
PA
MA
CA
NV
WY
NE
MO
KY
WV
VA
MD
AZ
UT
CO
KS
AR
TN
NC
SC
DE
NM
OK
TX
LA
MS
AL
GA
FL
NJ
Available Now Coming Soon

Texas Detail

Planned locations shown below — Coming Summer 2026

Texas Franchise Map
Dallas (3)
Fort Worth (2)
Austin (2)
Cedar Park (1)
San Antonio (2)
Houston (5)